Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Dec 1;10(12):1569. doi: 10.3390/pathogens10121569

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Final outcome by presence of efavirenz/nevirapine pre-treatment drug resistance and prior exposure to antiretroviral drugs in a cohort of Mexican persons living with HIV, 2017–2019. Note: Groups according to prior ART exposure and presence of NNRTI-PDR: EXP + noRES: experienced + non-resistant, EXP + RES: experienced + resistant, NAÏVE + noRES: naïve + non-resistant and NAÏVE + RES: naïve + resistant LTFU, lost to follow-up: defined as persons with a non-active status due to ART abandonment, migration to other healthcare systems, unknown status, as well as lack of viral load follow-up for more than 6 months at the dataset closure date.